Determination of methylation status of DAPK gene in salivary gland tumour tissues and its association with HPV 16 & 18 positivity
Abstract
Salivary gland tumours (SGTs) are heterogeneous neoplasms with diagnostic challenges due to morphological diversity. This study explored methylation status of DAPK gene in SGTs and its association with HPV16/18 and p16 protein expression. A total of 45 formalin-fixed, paraffin-embedded SGT samples were analysed using immunohistochemistry and methylation-specific PCR. Among the cases, 66.67% were benign and 33.34% malignant. DAPK methylation was associated with tumour type but not with HPV markers. Overall, HPV16 L1, HPV16/18 E6, and p16 expression were observed in 68%, 88%, and 77% of cases, respectively, with a higher frequency noted in benign tumours. Patterns observed through hierarchical clustering suggested potential differences in molecular profiles between benign and malignant SGTs; however, these findings remain exploratory, as this distribution deviates from established HPV biology, where E6 expression is typically associated with malignancy, suggesting potential non-specific immunoreactivity or methodological limitations. Overall, DAPK methylation exhibited a heterogeneous pattern across samples, indicating that epigenetic alterations may occur independently of HPV-driven mechanisms in SGTs. While distinct molecular patterns were observed, their biological significance remains uncertain. In conclusion, this study shows an association between DAPK methylation and tumour type in SGTs but does not support a definitive role of HPV in driving these epigenetic changes. The findings also highlight limitations associated with reliance on IHC without molecular HPV confirmation. Further studies incorporating PCR-based HPV typing, functional validation, and larger cohorts are required to clarify these relationships.
Related
- Coordinated alterations in SWI/SNF chromatin remodeling complex, mRNA splicing and mRNA methylation as hallmarks of salivary gland adenoid cystic carcinoma (SACC)
- Distinct genome-wide salivary DNA methylation changes following superset and repeated sprint training in youth male basketball players
- Association of salivary function with oral health-related quality of life in patients with type 2 diabetes and xerostomia: cross-sectional study
- Association of Postoperative Stress Hyperglycemia Ratio with Suspected Infection, Culture Positivity, Sepsis, and Septic Shock in 1408 Patients After Cranial Neurosurgery
- Association of phenotypic and functional characteristics of regulatory T cells from minor salivary glands with expression of the delta 7 FoxP3 splice variant in patients with Sjögren’s disease
BibTeX
@article{meer2026determination,
title = {{Determination of methylation status of DAPK gene in salivary gland tumour tissues and its association with HPV 16 & 18 positivity}},
author = {Anzila Meer and Sarina Sulong and Anani Aila Mat Zin and Rohimah Mohamud and Norhafiza Mat Lazim},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74177-0},
url = {https://www.nature.com/articles/s41598-026-74177-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Determination of methylation status of DAPK gene in salivary gland tumour tissues and its association with HPV 16 & 18 positivity
AU - Anzila Meer
AU - Sarina Sulong
AU - Anani Aila Mat Zin
AU - Rohimah Mohamud
AU - Norhafiza Mat Lazim
PY - 2026
DA - 2026/10/07
JO - Scientific Reports
DO - 10.1038/s41598-026-74177-0
UR - https://www.nature.com/articles/s41598-026-74177-0
AB - Salivary gland tumours (SGTs) are heterogeneous neoplasms with diagnostic challenges due to morphological diversity. This study explored methylation status of DAPK gene in SGTs and its association with HPV16/18 and p16 protein expression. A total of 45 formalin-fixed, paraffin-embedded SGT samples were analysed using immunohistochemistry and methylation-specific PCR. Among the cases, 66.67% were benign and 33.34% malignant. DAPK methylation was associated with tumour type but not with HPV markers. Overall, HPV16 L1, HPV16/18 E6, and p16 expression were observed in 68%, 88%, and 77% of cases, respectively, with a higher frequency noted in benign tumours. Patterns observed through hierarchical clustering suggested potential differences in molecular profiles between benign and malignant SGTs; however, these findings remain exploratory, as this distribution deviates from established HPV biology, where E6 expression is typically associated with malignancy, suggesting potential non-specific immunoreactivity or methodological limitations. Overall, DAPK methylation exhibited a heterogeneous pattern across samples, indicating that epigenetic alterations may occur independently of HPV-driven mechanisms in SGTs. While distinct molecular patterns were observed, their biological significance remains uncertain. In conclusion, this study shows an association between DAPK methylation and tumour type in SGTs but does not support a definitive role of HPV in driving these epigenetic changes. The findings also highlight limitations associated with reliance on IHC without molecular HPV confirmation. Further studies incorporating PCR-based HPV typing, functional validation, and larger cohorts are required to clarify these relationships.
SN - 2045-2322
ER -